טוען...
The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers
BACKGROUND: Limited data exist on the real‐world costs of applying whole‐genome analysis (WGA) in a clinical setting. We estimated the costs of applying WGA to guide treatments for patients with advanced cancers and characterized how costs evolve over time. METHODS: The setting is the British Columb...
שמור ב:
| הוצא לאור ב: | Mol Genet Genomic Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5441418/ https://ncbi.nlm.nih.gov/pubmed/28546995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.281 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|